Multiple reports highlighted that resistin is a biomarker of inflammation in diabetes as well as in many other inflammatory conditions, like sepsis, inflammatory bowel disease as well as rheumatoid arthritis [35, 36]. This evidence concerns the gene RETN and inflammatory bowel disease.